[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENT

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Phenylketonuria Market

3.3       Key Market Trends

3.3.1   Drivers

3.3.2   Restraints

3.3.3   Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1   Bargaining Power of Suppliers

3.4.2   Bargaining Power of Buyers

3.4.3   Threat of Substitution

3.4.4   Threat of New Entrants

3.4.5   Competitive Rivalry

4.         By Product Type

4.1       Introduction

4.1.1   Market Size & Forecast (Value)

4.2       Drug

4.2.1   Kuvan

4.2.2   Biopten

4.3       Dietary Supplement

5.          By Rout of Administration

5.1       Introduction

5.1.1   Market Size & Forecast (Value)

5.2       Oral Route

5.2.1  tablets and Capsules

5.2.2   Syrups

5.2.3   Powder

5.3       Parenteral Route

5.3.1   Intravenous

5.3.2   Subcutaneous

6.         By Distribution Channel

            6.1       Introduction

      6.1.1   Market Size & Forecast (Value)

6.2       Drug Stores

6.3       Online Pharmacies

6.4       Pediatric Clinics

7.         By Regional Overview        

7.1      Introduction 

7.1.1   Market Size & Forecast (Value)      

7.2      America         

7.2.1   North America          

7.2.1.1 U.S.   

7.2.1.1.1          By Product Type      

7.2.1.1.2          By Rout of Administration

7.2.1.2 Canada         

7.2.1.2.1          By Product Type      

7.2.1.2.2          By Rout of Administration

7.2.1.3 Mexico          

7.2.1.3.1          By Product Type       

7.2.1.3.2          By Rout of Administration

7.2.2   South America          

7.2.2.1            By Product Type

7.2.2.2            By Rout of Administration

7.3      Europe           

7.3.1   Market Size & Forecast (Value)      

7.3.2   Western Europe

7.3.2.1 Germany      

7.3.2.1.1         By Product Type       

8.3.2.1.2         By Rout of Administration  

7.3.2.2 France           

7.3.2.2.1         By Product Type       

7.3.2.2.2         By Rout of Administration  

7.3.2.3 U.K    

7.3.2.3.1         By Product Type       

7.3.2.3.2         By Rout of Administration  

7.3.2.4 Italy   

7.3.2.4.1         By Product Type       

7.3.2.4.2         By Rout of Administration  

7.3.2.5 Spain 

7.3.2.5.1         By Product Type       

7.3.2.5.2         By Rout of Administration  

7.3.2.6 Rest of Western Europe     

7.3.2.6.1         By Product Type

7.3.2.6.2         By Rout of Administration

7.3.3   Eastern Europe

7.4      Asia Pacific    

7.4.1   Market Size & Forecast (Value)      

7.4.2   China 

7.4.2.1             By Product Type

7.4.2.2             By Rout of Administration

7.4.3   India

7.4.3.1             By Product Type

7.4.3.2             By Rout of Administration

7.4.4   Japan 

7.4.4.1             By Product Type       

7.4.4.2             By Rout of Administration  

7.4.5   South Korea  

7.4.5.1             By Product Type       

7.4.5.2             By Rout of Administration  

7.4.6   Australia        

7.4.6.1            By Product Type       

7.4.6.2            By Rout of Administration  

7.4.7   Rest of Asia-Pacific   

7.4.7.1            By Product Type       

7.4.7.2            By Rout of Administration  

7.5       Middle East & Africa

7.5.1   Market Size & Forecast (Value)      

7.5.2   The Middle East

7.5.2.1     South Africa

7.5.2.1.1         By Product Type       

7.5.2.1.2         By Rout of Administration  

7.5.2.2     UAE

7.5.2.2.1         By Product Type       

7.5.2.2.2         By Rout of Administration  

7.5.2.3     Qatar

7.5.2.3.1         By Product Type       

7.5.2.3.2         By Rout of Administration  

7.5.2.4     Rest of Middle East

7.5.2.4.1         By Product Type

7.5.2.4 2         By Rout of Administration

7.5.3   Africa

7.5.3.1             By Product Type       

7.5.3.2             By Rout of Administration

8.         Company Profile                 

8.1       Ambrooke Therapeutics

8.1.1   Company Overview 

8.1.2   Financial Performance         

8.1.3   Recent Developments         

8.1.4   Product Portfolio     

8.2       Daiichi Sankyo Company Limited

8.2.1   Company Overview 

8.2.2   Financial Performance         

8.2.3   Recent Developments         

8.2.4   Product Portfolio     

8.3       American Gene Technologies International, Inc.

8.3.1   Company Overview 

8.3.2   Financial Performance         

8.3.3   Recent Developments         

8.3.4   Product Portfolio     

8.4       Koninklijke Philips

8.4.1   Company Overview 

8.4.2   Financial Performance         

8.4.3   Recent Developments         

8.4.4   Product Portfolio     

8.5       Dimension Therapeutics, Inc.

8.5.1   Company Overview 

8.5.2   Financial Performance         

8.5.3   Recent Developments         

8.5.4   Product Portfolio     

8.6       Synthetic Biologics, Inc.

8.6.1   Company Overview 

8.6.2   Financial Performance         

8.6.3   Recent Developments         

8.6.4   Product Portfolio     

8.7       SOM Innovation Biotech SL

8.7.1   Company Overview 

8.7.2   Financial Performance         

8.7.3   Recent Developments         

8.7.4   Product Portfolio     

8.8       Codexis, Inc.

8.8.1   Company Overview 

8.8.2   Financial Performance         

8.8.3   Recent Developments         

8.8.4   Product Portfolio     

8.9       BioMarin Pharmaceutical, Inc.

8.9.1   Company Overview 

8.9.2   Financial Performance         

8.9.3   Recent Developments         

8.9.4   Product Portfolio

8.10    Erytech Pharma SA

8.10.1 Company Overview 

8.10.2 Financial Performance         

8.10.3 Recent Developments         

8.10.4 Product Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports